OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Health Politics Policy and Law is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
The Unequal Pandemic: COVID-19 and Health Inequalities	30
Scripting Death: Stories of Assisted Dying in America	25
Section 1115 Substance Use Disorder Waivers: Opportunities and Limitations	23
Same as It Ever Was? Persistence and Transformation in US Health Care Policy	21
The Politics of the Gender Gap in COVID-19: Partisanship, Health Behavior, and Policy Preferences in the United States	19
MAHA Will Not Make Americans Healthy Again: The Politicization of US Federal Health Agencies During the Second Trump Administration	18
The Impacts of Politicization on Public Health Workers: The COVID-19 Pandemic in Oregon and Montana	17
Public Health Under Attack: Continuity, Discontinuity, and History	17
EU Economic Governance as a Supranational Determinant of Health Inequalities in the Eurozone	17
Entrenching Inequity, Eroding Democracy: State Preemption of Local Housing Policy	16
Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al.	16
The Limits to Food and Beverage Industry Influence over Fiscal and Regulatory Policy in Latin America	16
Why Some Nonelderly Adult Medicaid Enrollees Appear Ineligible Based on Their Annual Income	16
Ultimate Price: The Value We Place on Life	13
Using New Techniques to Examine the Past: A Computational Assessment of the First 50 Years of the Journal of Health Politics, Policy and Law	13
Implementing Primary Care Reform in France: Bargaining, Policy Adaptation, and the Maisons de Santé Pluriprofessionnelles	12
Medicaid's Political Development since 1965: How a Fragmented and Unequal Program Has Expanded	12
Medicare for All—Running Down a Dream	12
State Courts, State Legislatures, and Setting Abortion Policy	12
The EU as a Political Determinant of Global Health: The Case of Research and Development Incentives for Orphan Medicines and Biotechnology	11
The Evolution of Long-Term Care and Health Policy in the United States	10
State Efforts to Regulate Provider Networks and Directories: Lessons for the Future	10
Hospital Consolidation Across Geographic Markets: Insights from Market Participants on Mechanisms for Price Increases	10
Does Policy Uncertainty Boost Vaccine Hesitancy? Political Controversy, the FDA, and COVID-19 Vaccine Hesitancy in Fall 2020	9
Building Power for Health: The Grassroots Politics of Sustaining and Strengthening Medicaid	9

Market Failure, State Failure: The Political Economy of Supply Chain Strengthening to Ensure Equitable Access to Vaccines and Medicines in Low- and Middle-Income Countries	9
Variation in Public Support for Government Action on Unexpected Medical Bills	8
What the Evolution of 1332 Waivers Tells Us about Their Innovative Potential	8
How War Kills: The Overlooked Threats to Our Health	8
Vaccine Nationalism: How China's State Media Misinform about Western Vaccines and Highlight the Successes of Chinese Vaccines to Different Audiences	8
Grow and Hide: The History of America's Health Care State.	8
From Relf v. Weinberger to Drive-Through Delivery: Unpacking Democratic Responsiveness and Administrative Levers in U.S. Sterilization Policy	7
Strategies to Promote Vaccine Uptake in the COVID-19 Pandemic: Exploring the “Ladder of Intrusiveness” in Three Countries	7
When Protections Work but Processes Stall: Evaluating the No Surprises Act's Implementation Record	7
Criminal Records and Licensure in Five Allied Health Professions: Is There Evidence of a Disparate Impact on Historically Marginalized Groups?	7
Which US States Are Most Generous in Their Medicaid Policies and Why?	7
Introduction: The Politics of Abortion 50 Years afterRoe	7
Medicaid Waivers to Address Homelessness: Political Development and Policy Trajectories	6
Is Redistribution Good for Our Health? Examining the Macrocorrelation between Welfare Generosity and Health across EU Nations over the Last 40 Years	6
Science and Public Health in the Trump Era: The Dismantling of Evidence and Institutions, and Proposals for Reconstruction	6
The Political Economy of Market Power in Pharmaceuticals	6
It’s Only a Crisis if It’s Fit to Print: Examining the Relationship Between Overdose Rates, News Coverage, and the Presence of the Opioid Crisis in State Legislative Campaigns	6
Patent Litigation and the Timing of Entry by Biologic Biosimilars Compared to Small Molecule Generics in the U.S., 2015–2015	6
Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices	6
Administering a Chill Pill? Better Regulation and the Potential for Regulatory Chill in European Union Health Policy	5
Entrenched Opportunity: Medicaid, Health Systems, and Solutions to Homelessness	5
The Changing Politics of Guns in America	5
The Political Determinants of Health and the European Union	5
Intellectual Property and the Politics of Public Good during COVID-19: Framing Law, Institutions, and Ideas during TRIPS Waiver Negotiations at the WTO	5
In Covid's Wake: How Our Politics Failed Us	5
Medicare at 60: A Popular Program Facing Challenges	5
Lots of Pain for Little Gain: Three Decades of Medicaid Estate Recovery	5
Incentivizing COVID-19 Vaccination in a Polarized and Partisan United States	5
The Implications of the One Big Beautiful Bill Act (HR.1) for Long-Term Services and Supports	5